返回
RetinalGenix Technologies Inc（RTGN）價格
RTGN 股價走勢圖
RTGN 收益
RetinalGenix Technologies Inc
$3.2
0%
$0
收盤價：Jan 21, 16:00:00 GMT-5
$3.2
0%
$0
盤前：Jan 22, 06:56:01 GMT-5
關鍵數據
前收市價
$3.2
開盤價
$3.2
當日範圍
$3.2 - $3.54
52週區間
$3.2 - $4.01
交易量
2
平均成交量
3.3K
每股盈餘 (TTM)
-0.15
股息收益率
--
市值
$59.5M
什麼是 RTGN？
RetinalGeniX Technologies, Inc. operates as a medical device company. The company is headquartered in Petaluma, California and currently employs 0 full-time employees. The company went IPO on 2022-01-07. The firm's proprietary High-Resolution Retinal Imaging and DNA/RNA/GPS Pharmaco-Genetic Mapping technologies are designed to help prevent blindness by detecting initial physiological changes that could indicate future ocular and systemic diseases affecting neurodegenerative, cardiovascular, vascular and metabolic systems, as well as diabetic conditions, Alzheimer’s disease and Parkinson’s disease. Its RetinalCam is an in-home/remote location patient-activated monitoring and imaging device offering real-time communication and alerting system for physicians available 24/7. The company is also engaged in the development of its product candidates: RTG-2023 and RTG-2024. RTG-2023 for the treatment of dry age-related macular degeneration (dry AMD). RTG-2024 for the treatment of Alzheimer’s syndrome dementia.
